Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD5 | Q86SK9 | 11/20 | 0.43 |
| ▸ | SCD | O00767 | 5/20 | 0.42 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.40 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4504473 | 0.88 | ALDH1A1 (0.46) | SCD5SCDMRGPRX4ALDH1A1SMN1; SMN2 | |
| SCHEMBL4492919 | 0.86 | ALDH1A1 (0.51) | SCD5SCDALDH1A1SMN1; SMN2 | |
| SCHEMBL4512260 | 0.85 | SCD5 (0.45) | SCD5CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL4515727 | 0.84 | SCD5 (0.48) | SCD5SCDCYP2C8CYP2C9CYP2B6 | |
| SCHEMBL4505841 | 0.83 | MEN1 (0.43) | CYP2C9CYP2C19MRGPRX4ALDH1A1SMN1; SMN2 | |
| SCHEMBL4516523 | 0.81 | SCD (0.51) | SCD5SCDSGMS2CYP2C8CYP2B6 | |
| SCHEMBL4504477 | 0.81 | SMN1; SMN2 (0.43) | SCD5SCDCYP2C9CYP2C19MRGPRX4 | |
| Hydrochloric Acid SCHEMBL4518322 | 0.76 | MRGPRX4 (0.46) | SGMS2MRGPRX4ANO1 | |
| Trifluoroacetic Acid SCHEMBL4508314 | 0.75 | SMN1; SMN2 (0.49) | SCD5SCDMRGPRX4ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4508956 | 0.75 | SCD5 (0.52) | SCD5SCDMRGPRX4ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325956-A1 | Aromatic amine derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325956-A1 | Aromatic amine derivative and use thereof | SCD, SCD5, SMS | SCD5 2/4885SCD 1/4885SGMS2 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.